Comments
Drug maker Ipca Laboratories on Saturday reported 38 per cent rise in consolidated net profit at Rs 266.7 crore for the second quarter ended September 30, 2020.
The company had posted a net profit of Rs 193.5 crore for the year-ago period.
Revenue from operations rose to Rs 1,361.1 crore in the quarter as against Rs 1,283.9 crore in the same period a year ago.
On a standalone basis, the company posted a net profit of Rs 275.68 crore, up 41 per cent from Rs 196.02 crore in July-September 2019-20.
The company’s board has declared an interim dividend of Rs 8 per share (400 per cent) for 2020-21, Ipca Labs said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.